PROSPECTIVE STUDY ON THE EFFECTIVENESS OF PLATELET-RICH PLASMA IN MANAGING CHRONIC PLANTAR FASCIITIS

Authors

  • A. M. ILIAS BASHA Department of Orthopaedics, Kurnool Medical College, Kurnool, Andhra Pradesh, India.
  • SHAIK RASOOL Department of Orthopaedics, Kurnool Medical College, Kurnool, Andhra Pradesh, India.
  • K. ANUSHA Department of Orthopaedics, Kurnool Medical College, Kurnool, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2024.v17i5.50195

Keywords:

Platelet-rich plasma, Chronic plantar fasciitis, Growth factors

Abstract

Objectives: The objectives of this study were as follows: (1) Assess the impact of a single dose of platelet-rich plasma (PRP) injection on visual analog scale (VAS) scores for heel pain. (2) Evaluate the functional outcome scores following PRP treatment for chronic plantar fasciitis. (3) Measure and confirm the restoration of plantar fascia thickness through ultrasound (USG) assessments. (4) Determine the safety and viability of local PRP injection as a treatment option for individuals with chronic plantar fasciitis.

Methods: This hospital-based prospective case series, spanning January 2019 to January 2020, enrolled 40 participants aged 25–65 with unilateral, persistent plantar fasciitis resistant to conservative treatment. Exclusion criteria included BMI ≥30, various pathologies, and recent injections. Ethical clearance was obtained, and participants received autologous PRP injections, with ultrasound measuring plantar fascia thickness. Post-injection, patients were monitored for adverse reactions, initiated stretching exercises, and progressed to weight-bearing activities after 6 weeks.

Results: The study cohort, averaging 45 years (standard deviation [SD] 7.7), primarily comprised females with the right-foot prevalence. Symptom duration averaged 20 weeks (SD 4.5). Pre-injection VAS scores (6.7±1.2) significantly improved at 6 weeks (2.9±0.6) and 12 weeks (2.0±0.9) post-PRP injection (p<0.001). Plantar fascia thickness reduced from 5.1 mm (SD 0.6) to 4.1 mm (SD 0.5) at 12 weeks (p<0.001) and regular foot thickness: 3.7 mm (SD 0.5).

Conclusion: The study reveals that a singular PRP injection brings about substantial and clinically meaningful enhancements in heel pain, functional outcomes, and the restoration of plantar fascia thickness, supported by ultrasound measurements. This underscores local PRP injection as a viable and safe therapeutic choice for those grappling with chronic plantar fasciitis.

Downloads

Download data is not yet available.

References

Nahin RL. Prevalence and pharmaceutical treatment of plantar fasciitis in United States adults. J Pain. 2018;19(8):885-96. doi: 10.1016/j. jpain.2018.03.003, PMID 29597082

Taunton JE, Ryan MB, Clement DB, McKenzie DC, Lloyd-Smith DR, Zumbo BD. A retrospective case-control analysis of 2002 running injuries. Br J Sports Med. 2002;36(2):95-101. doi: 10.1136/ bjsm.36.2.95, PMID 11916889

Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for plantar fasciitis: A matched case-control study. J Bone Joint Surg Am. 2003;85(5):872-7. doi: 10.2106/00004623-200305000-00015, PMID 12728038

Rano JA, Fallat LM, Savoy-Moore RT. Correlation of heel pain with body mass index and other characteristics of heel pain. J Foot Ankle Surg. 2001;40(6):351-6. doi: 10.1016/s1067-2516(01)80002-8, PMID 11777230

Weiler A, Helling HJ, Kirch U, Zirbes TK, Rehm KE. Foreign-body reaction and the course of osteolysis after polyglycolide implants for fracture fixation: An experimental study in sheep. J Bone Joint Surg Br. 1996;78(3):369-76. doi: 10.1302/0301-620X.78B3.0780369, PMID 8636168

Gupta R, Malhotra A, Masih GD, Khanna T, Kaur H, Gupta P, et al. Comparing the role of different treatment modalities for plantar fasciitis: A double-blind randomized controlled trial. Indian J Orthop. 2020;54(1):31-7. doi: 10.1007/s43465-019-00038-w, PMID 32257015

Buccilli TA Jr., Hall HR, Solmen JD. Sterile abscess formation following a corticosteroid injection for the treatment of plantar fasciitis. J Foot Ankle Surg. 2005;44(6):466-8. doi: 10.1053/j.jfas.2005.07.020, PMID 16257677

Acevedo JI, Beskin JL. Complications of plantar fascia ruptureassociated with corticosteroid injection. Foot Ankle Int. 1998;19(2):91-7. doi: 10.1177/107110079801900207, PMID 9498581

Lee TG, Ahmad TS. Intralesional autologous blood injection compared to corticosteroid injection for treatment of chronic plantar fasciitis. A prospective, randomized, controlled trial. Foot Ankle Int. 2007;28(9):984-90. doi: 10.3113/FAI.2007.0984, PMID 17880872

Buchbinder R. Clinical practice. Plantar fasciitis. N Engl J Med. 2004;350(21):2159-66. doi: 10.1056/NEJMcp032745, PMID 15152061

Lemont H, Ammirati KM, Usen N. Plantar fasciitis: A degenerative process (fasciosis) without inflammation. J Am Podiatr Med Assoc. 2003;93(3):234-7. doi: 10.7547/87507315-93-3-234, PMID 12756315

Cornwall MW, McPoil TG. Plantar fasciitis: Aetiology and treatment. J Orthop Sports Phys Ther. 1999;29(12):756-60. doi: 10.2519/ jospt.1999.29.12.756, PMID 10612073

Toomey EP. Plantar heel pain. Foot Ankle Clin. 2009;14(2):229-45. doi: 10.1016/j.fcl.2009.02.001, PMID 19501805

Genc H, Saracoglu M, Nacir B, Erdem HR, Kacar M. Long-term ultrasonographic follow-up of plantar fasciitis patients treated with steroid injection. Joint Bone Spine. 2005;72(1):61-5. doi: 10.1016/j. jbspin.2004.03.006, PMID 15681250

Kiter E, Celikbas E, Akkaya S, Demirkan F, Kiliç BA. Comparison of injection modalities in treating plantar heel pain: A randomized controlled trial. J Am Podiatr Med Assoc. 2006;96(4):293-6. doi: 10.7547/0960293, PMID 16868321

Molloy T, Wang Y, Murrell G. The roles of growth factors in tendon and ligament healing. Sports Med. 2003;33(5):381-94. doi: 10.2165/00007256-200333050-00004, PMID 12696985

Martinelli N, Marinozzi A, Carnì S, Trovato U, Bianchi A, Denaro V. Platelet-rich plasma injections for chronic plantar fasciitis. Int Orthop. 2013;37(5):839-42. doi: 10.1007/s00264-012-1741-0, PMID 23250352

Ragab EM, Othman AM. Platelets-rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg. 2012;132(8):1065-70. doi: 10.1007/s00402-012-1505-8, PMID 22555761

Kumar V, Millar T, Murphy PN, Clough T. The treatment of intractable plantar fasciitis with platelet-rich plasma injection. Foot (Edinb). 2013;23(2-3):74-7. doi: 10.1016/j.foot.2013.06.002, PMID 23906977

Jain K, Murphy PN, Clough TM. Platelet-rich plasma versus corticosteroid injection for plantar fasciitis: A comparative study. Foot (Edinb). 2015;25(4):235-7. doi: 10.1016/j.foot.2015.08.006, PMID 26362235

Say F, Gürler D, İnkaya E, Bülbül M. Comparison of platelet-rich plasma and steroid injection in the treatment of plantar fasciitis. Acta Orthop Traumatol Turc. 2014;48(6):667-72. doi: 10.3944/ AOTT.2014.13.0142, PMID 25637732

Shetty VD, Dhillon M, Hegde C, Jagtap P, Shetty S. A study to compare the efficacy of corticosteroid therapy with platelet-rich plasma therapy in recalcitrant plantar fasciitis: A preliminary report. Foot Ankle Surg. 2014;20(1):10-3. doi: 10.1016/j.fas.2013.08.002, PMID 24480492

McMillan AM, Landorf KB, Barrett JT, Menz HB, Bird AR. Diagnostic imaging for chronic plantar heel pain: A systematic review and meta-analysis. J Foot Ankle Res. 2009;13(2):32. doi: 10.1186/1757-1146-2-32. PMID:19912628

Published

07-05-2024

How to Cite

BASHA, A. M. I., S. RASOOL, and K. ANUSHA. “PROSPECTIVE STUDY ON THE EFFECTIVENESS OF PLATELET-RICH PLASMA IN MANAGING CHRONIC PLANTAR FASCIITIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 5, May 2024, pp. 149-51, doi:10.22159/ajpcr.2024.v17i5.50195.

Issue

Section

Original Article(s)